Proficio Capital Partners LLC Takes Position in DENTSPLY SIRONA Inc. (NASDAQ:XRAY)

Proficio Capital Partners LLC acquired a new position in shares of DENTSPLY SIRONA Inc. (NASDAQ:XRAY) in the fourth quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor acquired 22,245 shares of the medical instruments supplier’s stock, valued at approximately $422,000.

Several other institutional investors and hedge funds have also added to or reduced their stakes in the stock. Riverview Trust Co bought a new stake in shares of DENTSPLY SIRONA during the fourth quarter worth $26,000. MassMutual Private Wealth & Trust FSB boosted its holdings in shares of DENTSPLY SIRONA by 648.4% during the 4th quarter. MassMutual Private Wealth & Trust FSB now owns 1,422 shares of the medical instruments supplier’s stock valued at $27,000 after acquiring an additional 1,232 shares in the last quarter. UMB Bank n.a. grew its position in DENTSPLY SIRONA by 60.8% during the 4th quarter. UMB Bank n.a. now owns 1,492 shares of the medical instruments supplier’s stock worth $28,000 after acquiring an additional 564 shares during the last quarter. Brooklyn Investment Group acquired a new position in DENTSPLY SIRONA in the 3rd quarter worth about $77,000. Finally, Quarry LP raised its position in DENTSPLY SIRONA by 455.0% in the third quarter. Quarry LP now owns 3,036 shares of the medical instruments supplier’s stock valued at $82,000 after purchasing an additional 2,489 shares during the last quarter. Institutional investors own 95.70% of the company’s stock.

Analysts Set New Price Targets

Several analysts have recently weighed in on XRAY shares. Robert W. Baird reduced their price target on DENTSPLY SIRONA from $22.00 to $20.00 and set a “neutral” rating on the stock in a report on Friday, February 28th. UBS Group reduced their target price on shares of DENTSPLY SIRONA from $35.00 to $27.00 and set a “buy” rating on the stock in a report on Tuesday, December 3rd. Morgan Stanley dropped their price target on shares of DENTSPLY SIRONA from $30.00 to $23.00 and set an “overweight” rating for the company in a research note on Tuesday, December 17th. Barrington Research reduced their price objective on shares of DENTSPLY SIRONA from $24.00 to $20.00 and set an “outperform” rating on the stock in a research note on Friday, February 28th. Finally, Evercore ISI restated an “in-line” rating and issued a $20.00 price objective on shares of DENTSPLY SIRONA in a report on Tuesday, January 7th. Twelve research analysts have rated the stock with a hold rating and three have issued a buy rating to the stock. According to MarketBeat.com, DENTSPLY SIRONA currently has a consensus rating of “Hold” and a consensus price target of $23.33.

DENTSPLY SIRONA Stock Performance

XRAY stock opened at $15.80 on Tuesday. The firm has a market cap of $3.14 billion, a PE ratio of -7.63, a price-to-earnings-growth ratio of 1.80 and a beta of 0.98. The company has a current ratio of 1.25, a quick ratio of 0.84 and a debt-to-equity ratio of 0.72. The stock has a 50-day moving average price of $17.86 and a 200-day moving average price of $20.40. DENTSPLY SIRONA Inc. has a 1-year low of $14.78 and a 1-year high of $33.42.

DENTSPLY SIRONA Dividend Announcement

The firm also recently announced a quarterly dividend, which will be paid on Friday, April 11th. Shareholders of record on Friday, March 28th will be issued a $0.16 dividend. The ex-dividend date is Friday, March 28th. This represents a $0.64 dividend on an annualized basis and a yield of 4.05%. DENTSPLY SIRONA’s payout ratio is currently -14.07%.

Insider Buying and Selling at DENTSPLY SIRONA

In related news, Director Gregory T. Lucier purchased 15,142 shares of DENTSPLY SIRONA stock in a transaction on Monday, March 3rd. The stock was acquired at an average cost of $16.51 per share, for a total transaction of $249,994.42. Following the completion of the acquisition, the director now owns 81,971 shares of the company’s stock, valued at $1,353,341.21. This trade represents a 22.66 % increase in their position. The purchase was disclosed in a legal filing with the SEC, which can be accessed through this link. Insiders own 0.52% of the company’s stock.

DENTSPLY SIRONA Profile

DENTSPLY SIRONA Inc manufactures and sells various dental products and technologies worldwide. It operates in four segments: Connected Technology Solutions, Essential Dental Solutions, Orthodontic and Implant Solutions, and Wellspect Healthcare. The company offers dental equipment comprising imaging equipment, motorized dental handpieces, treatment centers, other instruments, amalgamators, mixing machines, and porcelain furnaces; and dental CAD/CAM technologies to support dental restorations, such as intraoral scanners, 3-D printers, mills, other software and services, and a full-chairside economical restoration of esthetic ceramic dentistry, as well as DS Core, its cloud-based platform.